PHP243 - DO DISEASE SEVERITY AND/OR QUALITY OF CLINICAL DATA INFLUENCE PRICING POLICY IN FRANCE? AN ANALYSIS ON ORPHAN DRUGS AND BLOOD CANCERS TREATMENTS
Abstract
Authors
C. Vandewalle M. Charoy J. Heurtebis L. Desplanches M. Gauthier C. de Sauvebeuf